Class information for:
Level 1: NEPHROL S 151//ANALBUMINEMIA//IMPAIRED EXERCISE CAPACITY

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
4340 1728 40.9 71%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
255 19113 HEMODIALYSIS//BLOOD PURIFICATION//HAEMODIALYSIS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 NEPHROL S 151 Address 9 83% 0% 5
2 ANALBUMINEMIA Author keyword 5 30% 1% 15
3 IMPAIRED EXERCISE CAPACITY Author keyword 4 75% 0% 3
4 LIPID LIPOPROT Address 3 31% 1% 9
5 JOHN MOORHEAD Address 2 38% 0% 5
6 GLOMERULAR SCARRING Author keyword 2 67% 0% 2
7 INTER DIAGNOST Address 2 67% 0% 2
8 INTERNAL MED RENAL UNIT Address 2 67% 0% 2
9 NEPHROTIC RATS Author keyword 2 67% 0% 2
10 ATHEROGENIC LIPOPROTEINS Author keyword 2 29% 0% 5

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ANALBUMINEMIA 5 30% 1% 15 Search ANALBUMINEMIA Search ANALBUMINEMIA
2 IMPAIRED EXERCISE CAPACITY 4 75% 0% 3 Search IMPAIRED+EXERCISE+CAPACITY Search IMPAIRED+EXERCISE+CAPACITY
3 GLOMERULAR SCARRING 2 67% 0% 2 Search GLOMERULAR+SCARRING Search GLOMERULAR+SCARRING
4 NEPHROTIC RATS 2 67% 0% 2 Search NEPHROTIC+RATS Search NEPHROTIC+RATS
5 ATHEROGENIC LIPOPROTEINS 2 29% 0% 5 Search ATHEROGENIC+LIPOPROTEINS Search ATHEROGENIC+LIPOPROTEINS
6 PUROMYCIN AMINONUCLEOSIDE 1 10% 1% 13 Search PUROMYCIN+AMINONUCLEOSIDE Search PUROMYCIN+AMINONUCLEOSIDE
7 HEMODIALYSIS DURATION 1 38% 0% 3 Search HEMODIALYSIS+DURATION Search HEMODIALYSIS+DURATION
8 GLOMERULAR ATHEROSCLEROSIS 1 100% 0% 2 Search GLOMERULAR+ATHEROSCLEROSIS Search GLOMERULAR+ATHEROSCLEROSIS
9 IMAI RAT 1 100% 0% 2 Search IMAI+RAT Search IMAI+RAT
10 NON HIGH DENSITY LIPOPROTEIN HDL CHOLESTEROL 1 100% 0% 2 Search NON+HIGH+DENSITY+LIPOPROTEIN+HDL+CHOLESTEROL Search NON+HIGH+DENSITY+LIPOPROTEIN+HDL+CHOLESTEROL

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 REDUCES GLOMERULAR INJURY 80 65% 4% 76
2 PUROMYCIN INDUCED NEPHROSIS 50 88% 1% 23
3 EXCESS PARATHYROID HORMONE 27 92% 1% 11
4 CHRONIC AMINONUCLEOSIDE NEPHROSIS 22 68% 1% 19
5 LIPID ABNORMALITIES 16 24% 3% 58
6 LONG TERM SIMVASTATIN 14 100% 0% 7
7 UNITED KINGDOM HEART 13 80% 0% 8
8 FOCAL GLOMERULOSCLEROSIS 12 32% 2% 30
9 PAIR FED RATS 11 100% 0% 6
10 UREMIC DYSLIPOPROTEINEMIA 9 83% 0% 5

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease A Systematic Review and Meta-analysis 2012 93 101 54%
Lipid-Lowering Therapy in Persons With Chronic Kidney Disease A Systematic Review and Meta-analysis 2012 63 43 58%
KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient 2014 17 36 53%
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials 2008 209 77 51%
Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences 2006 149 76 70%
Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis 2013 31 42 52%
Do statins play a role in renoprotection? 2014 4 9 89%
Lipid Abnormalities in Patients with Chronic Kidney Disease: Implications for the Pathophysiology of Atherosclerosis 2013 15 78 51%
LIPOPROTEIN METABOLISM AND RENAL-FAILURE 1993 242 137 55%
LIPID ABNORMALITIES IN THE NEPHROTIC SYNDROME - CAUSES, CONSEQUENCES, AND TREATMENT 1994 103 100 66%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 NEPHROL S 151 9 83% 0.3% 5
2 LIPID LIPOPROT 3 31% 0.5% 9
3 JOHN MOORHEAD 2 38% 0.3% 5
4 INTER DIAGNOST 2 67% 0.1% 2
5 INTERNAL MED RENAL UNIT 2 67% 0.1% 2
6 RENAL STUDIES GRP 1 50% 0.1% 2
7 METAB LIPID GLUCOSE 1 33% 0.2% 3
8 VASC MED METAB 1 30% 0.2% 3
9 NUTR CLIN METAB 1 17% 0.2% 4
10 BIOSTAT NEPHROL 1 50% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000204416 POSTTRANSPLANT HYPERLIPIDEMIA//ABT LEBENSMITTELSICHERHEIT 1//APOLIPOPROTEIN DISTRIBUTION
2 0.0000097559 APA HAMSTER//APA HAMSTERS//ATHEROMATOUS LESION
3 0.0000093308 OBESITY RELATED GLOMERULOPATHY//SENSOR BIOANALYT SCI//HYPERFILTRATION NEPHROPATHY
4 0.0000085682 ADRIAMYCIN NEPHROPATHY//PUROMYCIN AMINONUCLEOSIDE//DOXORUBICIN NEPHROPATHY
5 0.0000082141 CARDIOVASC SPECIAL STUDIES//CARDIOVASC EDUC THER EUT CCRE//GEN INTERNAL MED SECT 111A 1
6 0.0000071220 GLYCATED ALBUMIN//CHRONIC KIDNEY DISEASE DETECTION//CHRONIC KIDNEY DISEASE STAGES
7 0.0000062092 RENAL VEIN THROMBOSIS//NEPHROL UROL TRANSPLANT IMMUNOL DERMATOL A//RENAL VENOUS THROMBOSIS
8 0.0000058387 PROTEIN ENERGY WASTING//JOURNAL OF RENAL NUTRITION//INTRADIALYTIC PARENTERAL NUTRITION
9 0.0000055668 NEPHROTIC EDEMA//CYCLOPHILIN LIKE PROTEIN//UNIT CARDIOVASC METAB PREVENT
10 0.0000055176 LIPOPROTEINA//APOLIPOPROTEINA//LIPOPROTEIN A